A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: Cancer and leukemia group B study 9181 Academic Article Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Decision Making
  • Magnetic Resonance Imaging
  • Mammography
  • Mastectomy, Segmental
  • Neoadjuvant Therapy

abstract

  • MA has limited activity in hormone-refractory prostate carcinoma, and there is no apparent dose-response correlation.

publication date

  • February 15, 2000

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/(SICI)1097-0142(20000215)88:4<825::AID-CNCR13>3.0.CO;2-N

PubMed ID

  • 10679652

Additional Document Info

start page

  • 825

end page

  • 34

volume

  • 88

number

  • 4